Skip to content

PTC Therapeutics PTCT Deferred Taxes

Deferred Taxes at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$9.22M-67.6%
United Therapeutics logo
United TherapeuticsUTHR
$25.9M
Biogen logo
BiogenBIIB
$23.6M+185%
Tenet Healthcare logo
Tenet HealthcareTHC
-$40M-1,100%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
-$13.11M+4.3%

Segments

By segment

See full
Life Science$347K-99.5%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's deferred taxes?
PTC Therapeutics (PTCT) reported deferred taxes of -$10K in Q1 2026.
How has PTC Therapeutics's deferred taxes changed year-over-year?
PTC Therapeutics's deferred taxes decreased by 600.0% year-over-year, from $2K to -$10K.
What is the long-term trend for PTC Therapeutics's deferred taxes?
Over 3 years (2021 to 2024), PTC Therapeutics's deferred taxes has grown at a 429.3% compound annual growth rate (CAGR), from $377K to -$55.91M.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.